日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

UBQLN1 Inhibition reduces MASH progression through downregulating SIKE/p38 MAPK pathway in hepatocyte.

UBQLN1 抑制通过下调肝细胞中的 SIKE/p38 MAPK 通路来减少 MASH 的进展。

Chen Yifei, Yang Fuji, Zheng Guojun, Wang Yanjin, Liu Likang, Yan Yongmin

OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease.

富含 OGT 的肝细胞来源的细胞外囊泡促进代谢功能障碍相关脂肪肝疾病中肝窦内皮细胞的毛细血管化。

Wang Yanjin, Zhou Xulin, Zhang Yu, Yang Fuji, Chen Yifei, Wu Yanshuang, Zhang Lin, Tan Junfei, Luo Wei, Zhou Jing, Yan Yongmin

ATP6V1B2 alleviates hepatic steatosis by promoting lysosomal acidification in hepatocytes.

ATP6V1B2 通过促进肝细胞溶酶体酸化来缓解肝脂肪变性。

Xu Ruizi, Yang Fuji, Zhang Zhuan, Cheng Fang, Li Shihui, Yan Yongmin, Wang Yanan, Zhou Jing

LIMA1 O-GlcNAcylation Promotes Hepatic Lipid Deposition through Inducing β-catenin-Regulated FASn Expression in Metabolic Dysfunction-Associated Steatotic Liver Disease.

LIMA1 O-GlcNAc糖基化通过诱导β-catenin调节的FASN表达促进代谢功能障碍相关脂肪肝疾病中的肝脏脂质沉积

Yang Fuji, Chen Yifei, Zheng Guojun, Gu Kefeng, Fan Lin, Li Tingfen, Zhu Ling, Yan Yongmin

MiR-4465-modified mesenchymal stem cell-derived small extracellular vesicles inhibit liver fibrosis development via targeting LOXL2 expression

miR-4465修饰的间充质干细胞来源的小细胞外囊泡通过靶向LOXL2表达抑制肝纤维化发展。

Wang, Yanjin; Chen, Yifei; Yang, Fuji; Yu, Xiaolong; Chu, Ying; Zhou, Jing; Yan, Yongmin; Xi, Jianbo

Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease

线粒体移植:治疗肥胖症、糖尿病和非酒精性脂肪肝疾病的机遇与挑战

Chen, Yifei; Yang, Fuji; Chu, Ying; Yun, Zhihua; Yan, Yongmin; Jin, Jianhua